Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Why Everyone Is Talking About Increasing GLP-1
Lilly announces $3bn expansion to injectable drug manufacturing facility The pharma giant is expanding its site in Pleasant Prairie, Wisconsin after acquiring the facility from Nexus in April
The starter dose of the Wegovy pill is now stocked at pharmacies nationwide, with higher doses rolling in shortly after launch, according to the manufacturer and national reporting
When prescribed appropriately and monitored by a qualified physician, GLP-1 medications have been shown to be effective and generally well tolerated in large clinical trials
Anti-inflammatory activity, if confirmed in humans, could potentially benefit conditions characterized by chronic inflammation, such as cardiovascular disease and metabolic syndrome
More recently, the FDA has approved select GLP-1 therapies specifically for weight loss, including: Wegovy (semaglutide) Saxenda (liraglutide) Zepbound, a GIP/GLP-1 dual-acting therapy (tirzepatide) How do they work
US$ 20.61
US$ 24.60
US$ 27.37
US$ 20.53
US$ 28.02
US$ 23.33
